Short Summary
ResMed Corp. successfully convinced the PTAB to institute IPR proceedings against Cleveland Medical Devices, Inc.'s patent (No. 11690512). The Board found that ResMed demonstrated a reasonable likelihood of prevailing on Ground 1, allowing the challenge to proceed despite neutral merits.
Detailed Summary
ResMed Corp. challenged U.S. Patent No. 11690512 owned by Cleveland Medical Devices, Inc. in an IPR proceeding based solely on obviousness (35 U.S.C. § 103). The Board analyzed the discretionary denial factors under Fintiv and determined that while the merits were neutral, Petitioner sufficiently demonstrated a reasonable likelihood of prevailing on Ground 1. Consequently, the Board granted institution, allowing ResMed to proceed with its challenge against claims 1-20 in the healthcare/sleep diagnostics technology space.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in ResMed Corp. vs Cleveland Medical Devices, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Apple Inc.vsNL Giken Inc.
Apple and NL Giken filed a joint motion to terminate IPR2024‑01277 after reaching a settlement. The Board is asked to end the proceeding under 35 U.S.C. §317.
OnePlus Technology (Shenzhen) Co., Ltd. et al.vsPantech Corporation
The USPTO denied OnePlus’s request for Director Review of the decision that had denied institution of Pantech’s patent 9,763,283. The denial leaves the institution denial standing.
Samsung Electronics Co., Ltd. et al.vsHannibal IP LLC
Hannibal IP asks the PTAB to deny Samsung’s IPR on its 5G beam‑management patent, arguing the prior‑art challenge is weak, Samsung knew of the patent for years, and the parallel litigation will finish before a PTAB decision.
Microsoft Corp.vsVirtaMove, Corp.
Microsoft and VirtaMove filed a joint motion requesting that their settlement agreement be treated as business confidential information under 35 U.S.C. §317(b). The parties argue the agreement contains highly sensitive information that could harm their businesses if disclosed.
Micron Technology, Inc. et al.vsPalisade Technologies, LLP
Micron filed an unopposed motion to dismiss its inter partes review of Palisade’s U.S. Patent No. 8,148,962 before the Board had decided whether to institute the case. The motion relies on the Board’s discretion to terminate early‑stage proceedings and cites prior PTAB decisions granting similar dismissals.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.